Aquestive Therapeutics, Inc. (AQST) KPIs and segments
Close on Nov 17, 2026Market cap $464.39MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Aquestive Therapeutics's business
Aquestive Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Manufacture and supply revenue($M) | 11.9 | 8.79 | 12.0 | 11.5 | 9.58 | 7.19 | 10.7 | 10.7 | 8.12 | 10.5 | 11.0 | 11.4 | |
License and royalty revenue (a)($M) | 1.33 | 5.40 | 0.85 | 1.04 | 0.84 | 0.79 | 0.83 | 2.16 | 11.2 | 1.13 | 1.87 | 1.10 | |
Royalty($M) | 0.98 | 0 | 0.02 | 0.01 | 0.91 | 0 | 1.94 | -0.01 | 1.98 | 0 | |||
Co-development and research fees($M) | 0.58 | 0.26 | 0.18 | 0.30 | 0.38 | 0.42 | 0.27 | 0.49 | 0.76 | 0.40 | 0.34 | 0.49 | |
Proprietary product revenue, net($M) | 0 | 0 | 0 | -0.80 | 0.32 | 0.22 | 0 | 0 | 0 | ||||
Earlier reporting (last reported 2023)1 | |||||||||||||
United States($M) | 11.0 | 13.2 | 9.39 | 10.1 | 4.89 | 5.20 | 9.33 | 10.5 | 9.64 | 10.4 | 11.7 | 9.89 | |
Ex-United States($M) | 2.83 | 1.20 | 3.63 | 2.68 | 5.11 | 3.52 | 2.54 | 3.01 | 10.5 | 1.63 | 1.47 | 3.11 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-11.
See a number that looks wrong?